3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Womens Cardiovascular Health: Cardiac Problems during Pregnancy
Rapidly increasing maternal morbidity and death continue to be mostly attributed to cardiovascular disease. Whenever both the pregnant woman and the developing foetus are exposed to several possible difficulties, various physiological changes of gestation happen. Women who have pre-existing cardiac conditions, such as congenital abnormalities, angina pectoris, coronary artery disease and aortopathies, need to undergo multidisciplinary testing, counselling, and optimization before getting pregnant. They also need to be closely monitored and have their medication needs managed. Close monitoring is crucial for patients who developed cardiac conditions like congestive heart failure, preeclampsia, cardiomyopathy, coronary events, or arrhythmia while pregnant. The signs of a cardiac issue during pregnancy include- fatigue, chest pain, shortness of breath, fainting, difficulty breathing while sleeping.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Miroslav Radenkovic
University of Belgrade, SerbiaSubmit your abstract Today
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through bio design-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico